Suggestions
Gregory Kopf
Director, Research & Development, Global Health, Population & Nutrition at FHI 360
Professional Background
Gregory Kopf is a distinguished Senior Executive and Scientist with extensive expertise in the fields of pre-clinical drug development, strategic planning, and biomedical research. With a career spanning several years in both academia and the pharmaceutical industry, Gregory has built a reputation for effectively aligning research and business objectives to foster impactful advancements in women's healthcare therapeutics.
Throughout his career, he has demonstrated a unique ability to interface between academic institutions and pharmaceutical organizations, which has allowed him to negotiate profitable alliances for various research initiatives. His strong background in pre-clinical target identification and validation places him at the forefront of bio-pharmaceutical innovation. As a leader, he has excelled in building and guiding cross-functional teams aimed at achieving critical objectives within research and development settings.
Education and Achievements
Gregory’s educational background is robust, having pursued his Ph.D. at the prestigious Vanderbilt University School of Medicine, alongside an undergraduate degree, Bachelor of Arts, from The College of Wooster. This foundational education has provided him with a solid understanding of the biomedical sciences and an analytical skill set crucial for his subsequent professional endeavors.
His professional trajectory includes holding significant leadership positions, such as the Director of Research & Development in Global Health, Population & Nutrition at FHI 360. Gregory's role involves overseeing research initiatives that aim to enhance health outcomes on a global scale, particularly in underserved populations.
Before his time at FHI 360, Gregory served as the Associate Vice Chancellor of Research Administration at University of Kansas Medical Center, where he made substantial contributions to the institution’s research strategy and administration. His leadership at the Kansas University Medical Center Research Institute as the Executive Director showcased his capability in advancing organizational goals through innovative research management.
Moreover, he held several prominent positions within Wyeth, including Interim Vice President and Assistant Vice President, which provided him with valuable insights into the intricacies of pharmaceutical operations. Additionally, as a Celso Ramon Garcia Professor of Obstetrics and Gynecology at the University of Pennsylvania, he contributed to the academic community by furthering research in women's health and engaging with the next generation of biomedical scientists.
Achievements
Gregory Kopf boasts an array of accomplishments that underscore his dedication to advancing therapeutic options in women's healthcare and improving outcomes through strategic research partnerships. His specialties include pre-clinical target identification, pre-clinical target validation, biomedical research, strategic planning, intellectual property evaluation, due diligence, government liaison, and research administration. Each of these areas of expertise plays a pivotal role in contributing to the success of drug development programs and ensuring that promising therapies progress through the necessary channels to reach patients.
With an excellent track record of consulting for the pharmaceutical industry and the National Institutes of Health, Gregory has successfully navigated complex landscapes, bringing critical innovations from the bench to clinical applications. His contributions have not only influenced clinical practices but have also paved the way for new public health initiatives, illustrating his commitment to enhancing global health outcomes.
In summary, Gregory Kopf is a highly regarded leader in the biomedical sector whose extensive background in drug development and his multifaceted expertise in academia and industry align to create a powerful force for change in women's healthcare. His career path reflects a steadfast dedication to improving therapeutic interventions and fostering collaborations aimed at enhancing the health and well-being of women globally.
